BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23833439)

  • 1. Induction of chronic renal failure in goats using Cisplatin: a new animal model.
    Mishra A; Chatterjee US; Mandal TK
    Toxicol Int; 2013 Jan; 20(1):56-60. PubMed ID: 23833439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in renal function in cats following treatment of hyperthyroidism using 131I.
    Adams WH; Daniel GB; Legendre AM; Gompf RE; Grove CA
    Vet Radiol Ultrasound; 1997; 38(3):231-8. PubMed ID: 9238796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
    Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of protein deprivation on the validity of creatinine and urea in evaluation of renal function. An experimental study in the goat.
    Valtonen MH; Uusi-Rauva A; Eriksson L
    Scand J Clin Lab Invest; 1982 Oct; 42(6):507-12. PubMed ID: 7156864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma urea and creatinine measurement.
    Özülker F; Özülker T; Uzun AK; Özpaçacı T
    Med Oncol; 2011 Dec; 28(4):1101-6. PubMed ID: 20467916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement between two routine methods of estimation of glomerular filtration rate in patients with advanced and terminal chronic renal failure.
    Garcia-Naveiro R; Rodriguez-Carmona A; Pérez-Fontán M
    Clin Nephrol; 2005 Oct; 64(4):271-80. PubMed ID: 16240898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of carprofen administered to healthy dogs anesthetized with propofol and isoflurane.
    Ko JC; Miyabiyashi T; Mandsager RE; Heaton-Jones TG; Mauragis DF
    J Am Vet Med Assoc; 2000 Aug; 217(3):346-9. PubMed ID: 10935037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a single blood sample and inulin to estimate glomerular filtration rate in rabbits.
    Michigoshi Y; Yamagishi N; Satoh H; Kato M; Furuhama K
    J Am Assoc Lab Anim Sci; 2011 Sep; 50(5):702-7. PubMed ID: 22330718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of iohexol, 51Cr-EDTA and endogenous creatinine for determination of glomerular filtration rate in pigs with reduced renal function: a comparison between different clearance techniques.
    Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S
    Scand J Clin Lab Invest; 1997 May; 57(3):241-52. PubMed ID: 9238760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal excretion of urea in response to changes in nitrogen intake in desert (black Bedouin) and non-desert (Swiss Saanen) goats.
    Silanikove N
    Comp Biochem Physiol A Comp Physiol; 1984; 79(4):651-4. PubMed ID: 6150801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the effects of the nitroimidazo-oxazine PA-824 on renal function in healthy subjects.
    Ginsberg AM; Laurenzi MW; Rouse DJ; Whitney KD; Spigelman MK
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3726-33. PubMed ID: 19528286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
    Laskow DA; Curtis JJ; Luke RG; Julian BA; Jones P; Deierhoi MH; Barber WH; Diethelm AG
    Am J Med; 1990 May; 88(5):497-502. PubMed ID: 2337107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of iohexol, chromium-51-ethylenediaminetetraacetic acid, and creatinine for determining the glomerular filtration rate in pigs with normal renal function: comparison of different clearance techniques.
    Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S
    Acad Radiol; 1996 Aug; 3(8):651-9. PubMed ID: 8796729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure.
    Lin HJ; Chao CL; Chien KL; Ho YL; Lee CM; Lin YH; Wu YW; Hsu RB; Chou NK; Wang SS; Chen CY; Chen MF
    Clin Res Cardiol; 2009 Aug; 98(8):487-92. PubMed ID: 19468780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of frusemide in chronic renal failure.
    Keeton GR; Morrison S
    Nephron; 1981; 28(4):169-73. PubMed ID: 7301002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.
    Funakoshi Y; Fujiwara Y; Kiyota N; Mukohara T; Shimada T; Toyoda M; Imamura Y; Chayahara N; Tomioka H; Umezu M; Otsuki N; Nibu K; Minami H
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):281-8. PubMed ID: 26791871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine.
    van Hoek I; Lefebvre HP; Peremans K; Meyer E; Croubels S; Vandermeulen E; Kooistra H; Saunders JH; Binst D; Daminet S
    Domest Anim Endocrinol; 2009 Jan; 36(1):45-56. PubMed ID: 19010632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
    Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
    Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.